Fundraising Fox
/Companies
Sign in

Canopy Biosciences

Saint Louis, US · Founded 2016 · Delaware LLC · 319 employees on LinkedIn · 7 known investors

Find your way into Canopy Biosciences

Sign up to see every warm intro you have to Canopy Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Canopy Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.

BiotechHealthtechMedical Devices

Founders & leadership

EWEDWARD WEINSTEIN
EDWARD WEINSTEINPresident and CEO2016–2022Edward Weinstein has over twenty years of experience in life sciences leadership, including previous work at Panome Bio. He brings expertise in genetic engineering and personalized medicine.
CW
CRYSTAL WINKELERChief Operating OfficerManaging Director at BioGenerator Ventures
CB
CHARLES BOLTENNamed on SEC filing
DK
DAVID KINGSLEYNamed on SEC filing

Board

DSDAVID SMOLLER
DAVID SMOLLERBoard directorGeneral Partner at Cultivation Capital

Investors · 7

BioGenerator Ventureslisted by BioGenerator VenturesSt. Louis · $50K – $250K

How we know: BioGenerator Ventures's portfolio page · techstartups.com · Not right? Tell us

Also in the syndicate · 5

Arch AngelsGreenleaf FundKingdom CapitalleadPinPoint HoldingsThe Missouri Technology Corporation (MTC)

Reported raises · per SEC filings

Form D private placements

$3.2M disclosed across 2 rounds · 2016–2017

▶$2.1MraisedJan 2018 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CHARLES BOLTENDirector
  • CRYSTAL WINKELERExecutive Officer
  • EDWARD WEINSTEINExecutive Officer, Director
  • DAVID SMOLLERDirector
  • DAVID KINGSLEYDirector
Offering amount
$3.4M
Amount sold
$2.1M
Minimum investment
$20K
First sale
Dec 2017
Incorporated
Limited Liability Company, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJul 2017 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • EDWARD WEINSTEINExecutive Officer, Director
  • DAVID SMOLLERDirector
  • CRYSTAL WINKELERExecutive Officer
  • CHARLES BOLTENDirector
  • DAVID KINGSLEYDirector
Offering amount
$1.1M
Amount sold
$1.1M
Minimum investment
$20K
First sale
Oct 2016
Incorporated
Limited Liability Company, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Canopy Biosciences went on to found or lead other companies.

David SmollerDirectorFounded Panome Bio +1Edward WeinsteinPresident, Chief Executive Officer and ManagerFounded Panome Bio

Frequently asked questions

What does Canopy Biosciences do?
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
Who are Canopy Biosciences's investors?
Canopy Biosciences's investors include Ampersand, BioGenerator Ventures.
How much funding has Canopy Biosciences raised?
Canopy Biosciences has disclosed $3.2M raised across 2 rounds.
Where is Canopy Biosciences headquartered?
Canopy Biosciences is headquartered in Saint Louis, US.